Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 6/20 | 0.62 |
| ▸ | TERT | O14746 | 3/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.61 |
| ▸ | PPARG | P37231 | 3/20 | 0.61 |
| ▸ | PPARD | Q03181 | 3/20 | 0.61 |
| ▸ | PPARA | Q07869 | 3/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.61 |
| ▸ | BLM | P54132 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | FABP4 | P15090 | 2/20 | 0.61 |
| ▸ | FAAH | O00519 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | F7 | P08709 | 2/20 | 0.61 |
| ▸ | F3 | P13726 | 2/20 | 0.61 |
| ▸ | GMNN | O75496 | 1/20 | 0.61 |
| ▸ | USP2 | O75604 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propane SCHEMBL480215 | 1.00 | FABP3 (0.62) | FABP3TERTPTPN1PPARGPPARD | |
| SCHEMBL7045888 | 0.98 | FABP3 (0.65) | FABP3TERTPTPN1PPARGPPARD | |
| SCHEMBL4133929 | 0.98 | FABP3 (0.65) | FABP3TERTPTPN1PPARGPPARD | |
| SCHEMBL1626315 | 0.98 | FABP3 (0.65) | FABP3TERTPTPN1PPARGPPARD | |
| Water SCHEMBL3915284 | 0.96 | FABP3 (0.62) | FABP3TERTPTPN1PPARGPPARD | |
| Iodide SCHEMBL6695071 | 0.96 | FABP3 (0.62) | FABP3TERTPTPN1PPARGPPARD | |
| Water SCHEMBL3915280 | 0.96 | FABP3 (0.62) | FABP3TERTPTPN1PPARGPPARD | |
| Bromide SCHEMBL3414482 | 0.96 | FABP3 (0.62) | FABP3TERTPTPN1PPARGPPARD | |
| Hydrochloric Acid SCHEMBL35815 | 0.96 | FABP3 (0.62) | FABP3TERTPTPN1PPARGPPARD | |
| Hydrochloric Acid SCHEMBL25963 | 0.96 | FABP3 (0.62) | FABP3TERTPTPN1PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4368657-A1 | PH-RESPONSIVE LIPID DERIVATIVE | NOF Corporation (JP) | 2024-05-15 | — | — | EP | claimed |
| WO-2023282296-A1 | PH-RESPONSIVE LIPID DERIVATIVE | 日油株式会社 | 2023-01-12 | — | — | WO | claimed |
| CN-112180079-A | Stable liposome particles and application thereof in immunoturbidimetric assay | 上海睿康生物科技有限公司 | 2021-01-05 | — | — | CN | claimed |
| EP-2729127-B1 | METHODS FOR PRODUCING LIPOSOMES | STATENS SERUMINSTITUT (DK) | 2018-05-02 | — | — | EP | claimed |
| WO-2017220099-A1 | ADJUVANTS WITH MODIFIED DRAINAGE PROPERTIES | STATENS SERUM INSTITUT (DK) | 2017-12-28 | — | — | WO | claimed |
| EP-2729127-A2 | METHODS FOR PRODUCING LIPOSOMES | Statens Serum Institut (DK) | 2014-05-14 | — | — | EP | claimed |
| US-20140112979-A1 | METHODS FOR PRODUCING LIPOSOMES | STATENS SERUM INSTITUT (DK) | 2014-04-24 | — | — | US | claimed |
| WO-2013004234-A2 | METHODS FOR PRODUCING LIPOSOMES | STATENS SERUM INSTITUT (DK) | 2013-01-10 | — | — | WO | claimed |
| EP-2167124-B1 | THE USE OF MONOMYCOLYL GLYCEROL (MMG) AS AN ADJUVANT | STATENS SERUMINSTITUT (DK) | 2012-08-01 | — | — | EP | claimed |
| US-6680068-B2 | Drug delivery formulations and targeting | THE GENERAL HOSPITAL CORPORATION | 2004-01-20 | — | — | US | claimed |
| US-20020090392-A1 | Drug delivery formulations and targeting | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-07-11 | — | — | US | claimed |
| WO-2002003959-A1 | DRUG DELIVERY FORMULATIONS AND TARGETING | THE GENERAL HOSPITAL CORPORATION (US) | 2002-01-17 | — | — | WO | claimed |
| EP-4368657-A1 | PH-RESPONSIVE LIPID DERIVATIVE | NOF Corporation (JP) | 2024-05-15 | — | — | EP | disclosed |
| CN-112180079-B | Stable liposome particle and application thereof in immune turbidimetry detection | 上海睿康生物科技有限公司 | 2024-04-19 | — | — | CN | disclosed |
| US-20230225972-A1 | LIPOSOMAL COMPOSITION FOR PREVENTING OR EARLY TREATMENT OF PATHOGENIC INFECTION | STATENS SERUM INSTITUT (DK) | 2023-07-20 | — | — | US | disclosed |
| EP-4135653-A1 | LIPOSOMAL COMPOSITION FOR PREVENTING OR EARLY TREATMENT OF PATHOGENIC INFECTION | Statens Serum Institut (DK) | 2023-02-22 | — | — | EP | disclosed |
| US-6071533-A | Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-06-06 | — | — | US | disclosed |
| WO-1999058694-A1 | METHODS OF FORMING PROTEIN-LINKED LIPIDIC MICROPARTICLES, AND COMPOSITIONS THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1999-11-18 | — | — | WO | disclosed |
| EP-0956001-A1 | PREPARATION OF STABLE FORMULATIONS OF LIPID-NUCLEIC ACID COMPLEXES FOR EFFICIENT $i(IN VIVO) DELIVERY | The Regents of the University of California (US) | 1999-11-17 | — | — | EP | disclosed |
| WO-1998020857-A1 | PREPARATION OF STABLE FORMULATIONS OF LIPID-NUCLEIC ACID COMPLEXES FOR EFFICIENT IN VIVO DELIVERY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-05-22 | — | — | WO | disclosed |